MedTrace Logo

Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals

NCT04456595 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 12688

Last updated 2024-02-15

No results posted yet for this study

Summary

This is a phase III clinical trial to assess efficacy and safety of the Adsorbed COVID-19 (inactivated) vaccine manufactured by Sinovac in health care professionals

Conditions

Interventions

BIOLOGICAL

Adsorbed COVID-19 (inactivated) Vaccine

Adsorbed COVID-19 (inactivated) Vaccine manufactured by Sinovac

BIOLOGICAL

Placebo

Placebo of Adsorbed COVID-19 (inactivated) Vaccine manufactured by Sinovac

Sponsors & Collaborators

  • Sinovac Life Sciences Co., Ltd.

    collaborator INDUSTRY

  • Butantan Institute

    lead OTHER_GOV

Principal Investigators

  • Ricardo Palacios, MD, PhD · Butantan Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-21
Primary Completion
2020-12-17
Completion
2022-02-17

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04456595 on ClinicalTrials.gov